Anxiety and mood (대한불안의학회지)

Korean Academy of Anxiety Disorders (대한불안의학회)
권호 표지
DOI QR코드

DOI QR Code

Mental Health of Asymptomatic or Mildly Symptomatic COVID19 Patients in the Seoul Metropolitan City Community Treatment Center: Cross Sectional Analysis of Depression, Anxiety, Trauma Experience, and Suicidal Tendency

서울 생활치료센터에 입소한 경증 혹은 무증상 코로나19 감염자의 정신건강: 우울, 불안, 외상경험, 자살위험성에 대한 단면 분석

  • Mun, Myeonghyeon (Department of Psychiatry, Seoul Medical Center) ;
  • Lee, Haewoo (Department of Psychiatry, Seoul Medical Center) ;
  • Yoo, Yongjoon (Department of Psychiatry, Seoul National University Hospital) ;
  • Shin, Juhee (Seoul Mental Health Welfare Center) ;
  • Ahn, Chiung (Seoul Mental Health Welfare Center)
  • 문명현 (서울특별시 서울의료원 정신건강의학과) ;
  • 이해우 (서울특별시 서울의료원 정신건강의학과) ;
  • 유용준 (서울대학교병원 정신건강의학과) ;
  • 신주희 (서울시정신건강복지센터) ;
  • 안치웅 (서울시정신건강복지센터)
  • Received : 2022.04.05
  • Accepted : 2022.06.23
  • Published : 2022.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : The purpose of this study was to investigate depression, anxiety, trauma experience, and suicidal tendency among patients who were hospitalized in a community treatment center and to identify the factors that were associated with each symptom. Methods : A total of 213 patients who were hospitalized in the Tae-reung community treatment center between March 16, 2020 and April 30, 2020 were recruited into this study. A self-report questionnaire or interview by mental health professionals was used to assess PHQ-2, GAD-7, PC-PTSC and P4 screener. In 90 patients who completed the survey, multiple regression modeling was conducted to identify the burden of each psychiatric symptoms and associated demographic characteristics. Results : Female gender was significantly positively associated with GAD-7 score, score of each GAD-7 subscale of 1, 2, 3 or 4 (nervous, control of worry, worry, and trouble relaxing), and sum of GAD-7 subscale scores reflecting cognitive and emotional experience of anxiety (1. nervous+2. control of worry+3. worry+7. afraid). Previous psychiatric history and, number of counseling service used were significantly positively associated with the PHQ-2 score and the duration of isolation was significantly negatively associated with the PHQ-2 score. Conclusion : These results showed that depression and anxiety symptoms were more prevalent in COVID-19 patients at the community treatment center than in the general population. Among the demographic characteristics, female gender was positively associated with cognitive and emotional experience of anxiety. It shows the necessity of an appropriate psychiatric intervention protocol and health-policy preparation for community treatment centers.

Keywords

References

  1. https://www.who.int/westernpacific/emergencies/covid-19.
  2. Nacoti M, Ciocca A, Giupponi A, Brambillasca P, Lussana F, Pisano M, et al. At the epicenter of the Covid-19 pandemic and humanitarian crises in Italy: changing perspectives on preparation and mitigation. NEJM Catal Innov Care Deliv. Forthcoming;2020.
  3. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline.
  4. Sun, P, Qie S, Liu Z, Ren J, Li K, Xi J. Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: a single arm meta-analysis. Journal of Medical Virology 2020;92:612-617. https://doi.org/10.1002/jmv.25735
  5. Kang EK, Lee SY, Jung HM, Kim MS, Cho BL, Kim YS. Operating protocols of a community treatment center for isolation of patients with coronavirus disease, South Korea. Emerging Infectious Diseases 2020;26:2329-2337. https://doi.org/10.3201/eid2610.201460
  6. Hyun JH, You SE, Sohn SJ, Kim SJ, Bae JY, Baik MJ, et al. Psychosocial support during the COVID-19 outbreak in Korea: activities of multidisciplinary mental health professionals. J Korean Med Sci 2020;35:e211. https://doi.org/10.3346/jkms.2020.35.e211
  7. Park HY. Mental health in patients with coronavirus disease-19 and the quarantined people. J Korean Neuropsychiatr Assoc 2021;60:11-18. https://doi.org/10.4306/jknpa.2021.60.1.11
  8. Park HY, Jung JT, Park HY, Lee SH, Kim ES, Kim HB, et al. Psychological consequences of survivors of COVID-19 pneumonia 1 month after discharge. J Korean Med Sci 2020;35:e409. https://doi.org/10.3346/jkms.2020.35.e409
  9. Maxime T, John RG, Masud H, Sierra L, Paul JH. 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry 2021:8:416-427. https://doi.org/10.1016/S2215-0366(21)00084-5
  10. Wang CY, Pan RY, Wan XY, Tan YL, Xu LK, McIntyre RS, et al. A longitudinal study on the mental health of general population during the COVID-19 epidemic in China. Brain, Behavior, and Immunity 2020;87:40-48. https://doi.org/10.1016/j.bbi.2020.04.028
  11. Lee YH, Hong CM, Kim DH, Lee TH, Lee J. Clinical course of asymptomatic and mildly symptomatic patients with coronavirus disease admitted to community treatment centers, South Korea. Emerg Infect Dis 2020;26:2346-2352. https://doi.org/10.3201/eid2610.201620
  12. Chen D, Song F, Tang L, Zhang H, Shao J, Qiu R, et al. Quarantine experience of close contacts of COVID-19 patients in China: a qualitative descriptive study. Gen Hosp Psychiatry 2020;66:81-88. https://doi.org/10.1016/j.genhosppsych.2020.07.006
  13. Korenke K, Spitzer RL, Williams JB. The patient health questionnaire-2: validity of a two-item depression screener. Med Care 2003;41:1284-1292. https://doi.org/10.1097/01.MLR.0000093487.78664.3C
  14. Choi HS, Choi JH, Park KH, Joo KJ, Ga H, Ko HJ, et al. Standardization of the Korean version of Patient Health Questionnaire-9 as a screening instrument for major depressive disorder. Korean J Fam Med 2007;28:114-119.
  15. Swinson RP. The GAD-7 scale was accurate for diagnosing generalised anxiety disorder. Evid Based Med 2006;11:184. https://doi.org/10.1136/ebm.11.6.184
  16. Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007;146:317-325. https://doi.org/10.7326/0003-4819-146-5-200703060-00004
  17. Seo JG, Park SP. Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine. J Headache Pain 2015;16:97. https://doi.org/10.1186/s10194-015-0583-8
  18. Prins A, Bovin MJ, Smolenski DJ, Marx BP, Kimerling R, Jenkins- Guarnieri MA, et al. The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): development and evaluation within a Veteran primary care sample. J GEN INTERN MED 2016;31:1206-1211. https://doi.org/10.1007/s11606-016-3703-5
  19. Jung YE, Kim D, Kim WH, Roh D, Chae JH, Park JE. A brief screening tool for PTSD: Validation of the Korean Version of the Primary Care PTSD Screen for DSM-5 (K-PC-PTSD-5). J Korean Med Sci 2018;33:52.
  20. Dube P, Kurt K, Bair MJ, Theobald D, Williams LS. The p4 screener: evaluation of a brief measure for assessing potential suicide risk in 2 randomized effectiveness trials of primary care and oncology patients. Primary Care Companion J Clin Psychiatry 2010;12:6.
  21. Beard C, Bjorgvinsson T. Beyond generalized anxiety disorder: psychometric properties of the GAD-7 in a heterogeneous psychiatric sample. J Anxiety Disord 2014;28:547-552. https://doi.org/10.1016/j.janxdis.2014.06.002
  22. Lee YM. National Mental Health Statistics 2020. National Center for Mental Health;2021.
  23. Hahm BJ. National Mental Health Survey 2021. National Center for Mental Health;2021.
  24. Wu KK, Chan SK, Ma TM. Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS). J Traum Stress 2005;18:39-42. https://doi.org/10.1002/jts.20004
  25. Deng J, Zhou F, Hou W, Silver Z, Wong CY, Chang O, et. al. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann NY Acad Sci 2021;1486:90-111. https://doi.org/10.1111/nyas.14506
  26. Liguori C, Pierantozzi M, Spanetta M, Sarmati L, Cesta N, Iannetta M, et al. Depressive and anxiety symptoms in patients with SARSCoV2 infection. J Affect Disord 2021;278:339-340. https://doi.org/10.1016/j.jad.2020.09.042
  27. Zhao YJ, Jin W, Rao WW, Li W, Zhao N, Cheung T, et al. The prevalence of psychiatric comorbidities during the SARS and COVID-19 epidemics: a systematic review and meta-analysis of observational studies. Journal of Affective Disorders 2021;287:145-157. https://doi.org/10.1016/j.jad.2021.03.016
  28. Response Guidance for Businesses to prevent and control the spread of COVID-19 Eighth edition. Ministry of Employment and labor;2020.
  29. Rutter LA, Brown TA. Psychometric properties of the Generalized Anxiety Disorder Scale-7 (GAD-7) in outpatients with anxiety and mood disorders. J Psychopathol Behav Assess 2017;39:140-146. https://doi.org/10.1007/s10862-016-9571-9